Araştırma Makalesi

Prediction of Mortality Using Hematological and Biochemical Markers in Pneumonia Patients Followed in the Intensive Care Unit: A Retrospective Observational Study

Cilt: 7 Sayı: 3 9 Eylül 2025
PDF İndir
EN

Prediction of Mortality Using Hematological and Biochemical Markers in Pneumonia Patients Followed in the Intensive Care Unit: A Retrospective Observational Study

Öz

Aim: Pneumonia remains a leading cause of mortality among patients admitted to intensive care units (ICUs). The use of hematological and biochemical markers has gained increasing importance in enhancing the accuracy of diagnosis and prognosis. Biomarkers such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), neutrophil-to-platelet ratio (NPR), and the C-reactive protein/albumin ratio, which are calculated using complete blood count parameters, may aid in assessing the severity of systemic inflammation and predicting mortality. Our study examined how NLR, PLR, NPR, and CRP/Albumin ratios affect mortality in ICU patients hospitalized with pneumonia. Material and Method: This retrospective observational study was conducted at a single center and involved 163 patients diagnosed with pneumonia and admitted to the ICU between May 1, 2021, and March 31, 2025. Demographic data, mortality status, and laboratory parameters at admission were obtained from the hospital information management system. Based on hematological (hemoglobin, neutrophil, lymphocyte, platelet) and biochemical (CRP, albumin) data, NLR, PLR, NPR, and CRP/Albumin ratios were calculated. Patients were categorized into survivors and non-survivors according to 30-day outcomes, and the relationship between the biomarker levels and mortality was analyzed statistically. Results: A cohort comprising 163 ICU patients diagnosed with pneumonia underwent evaluation, revealing a 30-day mortality rate of 35% (n=57) within this patient population. No significant differences in age or sex were observed between survivors and non-survivors (p>0.05). The CRP levels were significantly lower, while albumin and hemoglobin levels were significantly higher in the survivor group (p<0.05). The CRP/albumin ratio was significantly elevated in non-survivors (p=0.001). Although no statistically significant differences were found for NLR, PLR, and NPR between the groups, these markers tended to be lower in survivors. Conclusion: According to the findings of our study, low hemoglobin and albumin levels, as well as high CRP levels and CRP/Albumin ratios, were associated with mortality. NLR, PLR and NPR were found to be high in survivors, although not statistically significant. The CRP/Albumin ratio stands out as a reliable biomarker for predicting mortality, whereas NLR, PLR, and NPR, despite their limited sensitivity, may be used as supportive parameters due to their high specificity.

Anahtar Kelimeler

Etik Beyan

This study was approved by the Clinical Research Ethics Committee of Ordu University (Date: April 11, 2025; Application No: BAEK 128; Decision No: 2025/118).

Kaynakça

  1. Messinger AI, Kupfer O, Hurst A, Parker S. Management of pediatric community-acquired bacterial pneumonia. Pediatr Rev. 2017;38:394-409.
  2. Berg AS, Inchley CS, Fjaerli HO, et al. Clinical features and inflammatory markers in pediatric pneumonia: a prospective study. Eur J Pediatr. 2017;176:629-38.
  3. Pantzaris ND, Platanaki C, Pierrako C, et al. Neutrophil-to-lymphocyte ratio relation to sepsis severity scores and inflammatory biomarkers in patients with community-acquired pneumonia: a case series. J Transl Int Med. 2018;6:43-6.
  4. Graziano V, Grassadonia A, Iezzi L, et al. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients. Breast. 2019;44:33-8.
  5. Hirahara T, Arigami T, Yanagita S, et al. Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer. BMC Cancer. 2019;19:672.
  6. El-Gazzar AG, Kamel MH, Elbahnasy OKM, El-Naggar MES. Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients. Expert Rev Respir Med. 2020;14:111-6.
  7. Nour M, Hegazy A, Mosbah A, et al. Role of microalbuminuria and hypoalbuminemia as outcome predictors in critically Ill patients. Crit Care Res Pract. 2021;2021:6670642.
  8. Bekis Bozkurt H. Is there any relationship between C-reactive protein/albumin ratio and clinical severity of childhood community-acquired pneumonia. Turk J Biochem. 2021;46:647-53.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Göğüs Hastalıkları, Yoğun Bakım

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

9 Eylül 2025

Gönderilme Tarihi

13 Haziran 2025

Kabul Tarihi

5 Eylül 2025

Yayımlandığı Sayı

Yıl 2025 Cilt: 7 Sayı: 3

Kaynak Göster

APA
Kalaycı, H. Ö., Yılmaz, E. S., & Gürpınar, A. B. (2025). Prediction of Mortality Using Hematological and Biochemical Markers in Pneumonia Patients Followed in the Intensive Care Unit: A Retrospective Observational Study. Medical Records, 7(3), 774-9. https://izlik.org/JA56DU34NC
AMA
1.Kalaycı HÖ, Yılmaz ES, Gürpınar AB. Prediction of Mortality Using Hematological and Biochemical Markers in Pneumonia Patients Followed in the Intensive Care Unit: A Retrospective Observational Study. Med Records. 2025;7(3):774-9. https://izlik.org/JA56DU34NC
Chicago
Kalaycı, Hacer Özlem, Emine Serap Yılmaz, ve Ahmet Burak Gürpınar. 2025. “Prediction of Mortality Using Hematological and Biochemical Markers in Pneumonia Patients Followed in the Intensive Care Unit: A Retrospective Observational Study”. Medical Records 7 (3): 774-9. https://izlik.org/JA56DU34NC.
EndNote
Kalaycı HÖ, Yılmaz ES, Gürpınar AB (01 Eylül 2025) Prediction of Mortality Using Hematological and Biochemical Markers in Pneumonia Patients Followed in the Intensive Care Unit: A Retrospective Observational Study. Medical Records 7 3 774–9.
IEEE
[1]H. Ö. Kalaycı, E. S. Yılmaz, ve A. B. Gürpınar, “Prediction of Mortality Using Hematological and Biochemical Markers in Pneumonia Patients Followed in the Intensive Care Unit: A Retrospective Observational Study”, Med Records, c. 7, sy 3, ss. 774–9, Eyl. 2025, [çevrimiçi]. Erişim adresi: https://izlik.org/JA56DU34NC
ISNAD
Kalaycı, Hacer Özlem - Yılmaz, Emine Serap - Gürpınar, Ahmet Burak. “Prediction of Mortality Using Hematological and Biochemical Markers in Pneumonia Patients Followed in the Intensive Care Unit: A Retrospective Observational Study”. Medical Records 7/3 (01 Eylül 2025): 774-9. https://izlik.org/JA56DU34NC.
JAMA
1.Kalaycı HÖ, Yılmaz ES, Gürpınar AB. Prediction of Mortality Using Hematological and Biochemical Markers in Pneumonia Patients Followed in the Intensive Care Unit: A Retrospective Observational Study. Med Records. 2025;7:774–9.
MLA
Kalaycı, Hacer Özlem, vd. “Prediction of Mortality Using Hematological and Biochemical Markers in Pneumonia Patients Followed in the Intensive Care Unit: A Retrospective Observational Study”. Medical Records, c. 7, sy 3, Eylül 2025, ss. 774-9, https://izlik.org/JA56DU34NC.
Vancouver
1.Hacer Özlem Kalaycı, Emine Serap Yılmaz, Ahmet Burak Gürpınar. Prediction of Mortality Using Hematological and Biochemical Markers in Pneumonia Patients Followed in the Intensive Care Unit: A Retrospective Observational Study. Med Records [Internet]. 01 Eylül 2025;7(3):774-9. Erişim adresi: https://izlik.org/JA56DU34NC